Type 1 interferon deficiency: Biomarker of patients at risk of severe COVID-19
Friday, July 17, 2020 - 11:51
in Health & Medicine
Which patients are more likely to develop a severe form of COVID-19? In a new study, researchers describe a unique and unexpected immunological phenotype in severe and critical patients.